Related Experiment Video

Updated: Aug 29, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Management of reactive arthritis

Carlo Palazzi1, Ignazio Olivieri, Emilio D'Amico

  • 1Unità Operativa Reumatologia, Casa di Cura, Villa Pini d'Abruzzo, Via Dei Frentani, 228, Chieti, Italy. kaps57@virgilio.it

Expert Opinion on Pharmacotherapy
|December 19, 2003
PubMed

Insights

Reactive arthritis (ReA) is joint inflammation triggered by infections. Treatment typically involves NSAIDs, but advanced therapies like TNF-alpha blockers may be needed for severe cases.

Area of Science:

  • Rheumatology
  • Immunology
  • Infectious Diseases

Background:

  • Reactive arthritis (ReA) is an aseptic inflammatory condition.
  • It is triggered by gastrointestinal or urogenital infections.
  • Common causative bacteria include Chlamydia, Salmonella, Shigella, Campylobacter, and Yersinia.

Purpose of the Study:

  • To review the current understanding of reactive arthritis.
  • To outline the typical clinical presentation and common treatments.
  • To discuss emerging therapeutic options for refractory cases.

Main Methods:

  • Literature review of reactive arthritis.
  • Analysis of clinical manifestations and etiological agents.
  • Evaluation of current and potential treatment strategies.

Main Results:

  • ReA commonly presents as lower limb oligoarthritis, with frequent extra-articular manifestations.
  • Non-steroidal anti-inflammatory drugs (NSAIDs) and sulfasalazine are first-line treatments.
  • Steroids, other DMARDs, and antibacterials have roles in specific situations.
  • TNF-alpha blockers show promise for aggressive or evolving cases.

Conclusions:

  • Reactive arthritis requires a multifaceted treatment approach.
  • Early and appropriate management is crucial for patient outcomes.
  • Further research into novel therapies like TNF-alpha blockers is warranted for severe ReA.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.